Published in Women's Health Weekly, July 20th, 2006
According to recent research from Hungary, "IHC reveals a higher rate of occult lymph node metastases among lobular carcinomas than among ductal breast cancers. IHC is widely used but is seldom recommended for the evaluation of sentinel lymph nodes in breast cancer patients."
"[The study's aim was] to assess the value of cytokeratin IHC for the detection of metastases in sentinel lymph nodes of patients with invasive lobular carcinoma," explained G. Cserni and colleagues, Bacs Kiskun County Teaching Hospital. "The value of IHC, the types of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly